61909 Evidence-based hair care products and practices to use while scalp cooling
Recommended Citation
Kaufman L, Rose L, Ueltschi O, Rojas S, Schoettinger K, Novice M, Novice T, Salkey K, Hordinsky M, Dulmage B. 61909 Evidence-based hair care products and practices to use while scalp cooling. J Am Acad Dermatol 2025; 93:AB47.
Document Type
Conference Proceeding
Publication Date
9-1-2025
Publication Title
J Am Acad Dermatol
Abstract
Background: Scalp cooling therapy (SCT) is increasingly used to help mitigate chemotherapy-induced hair loss, but evidence-based recommendations for hair care during SCT are limited. Recommendations from SCT company websites, Facebook groups, and online articles are often based on personal experiences rather than clinical evidence. Objective: This paper evaluates common hair care recommendations in the SCT community to provide clinicians, patients, and the hair care industry with evidence-based guidelines. Methods: Hair care recommendations for SCT were reviewed from the websites and user guides of leading SCT providers. A literature search focused on clinical evidence supporting hair care, supplementation, sleeping caps, silk pillowcases, use of heating tools, chemical exposure, and activity recommendations. Results: Recommendations across companies align in some areas, though scientific support varies. Sulfate-free shampoos are widely encouraged to prevent hair dryness, and companies agree on washing hair less frequently to minimize scalp stress. Chemical treatments should be avoided, as they can cause structural damage, and biotin is not recommended for hair regrowth due to insufficient evidence. Satin or silk pillowcases are suggested to minimize hair friction. While oils are recommended by many companies, their benefits are not well defined. Heating tools are discouraged, and activities that cause excessive hair friction or drying should be avoided. Conclusion: Despite the growing adoption of SCT, scientific evidence on optimal hair care during treatment is sparse, leading to inconsistent recommendations. Standardized, evidence-based guidelines are needed to help patients make informed decisions and reduce the emotional toll of chemotherapy-induced hair loss.
Volume
93
First Page
AB47
